<?xml version="1.0"?>
<Articles JournalTitle="Frontiers in Biomedical Technologies">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Frontiers in Biomedical Technologies</JournalTitle>
      <Issn>2345-5837</Issn>
      <Volume>2</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2015</Year>
        <Month>09</Month>
        <Day>30</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Compartmental Analysis to Predict the Biodistribution of [166Ho]- DOTA-Bevacizumab for Targeted Radiotherapy Purpose</title>
    <FirstPage>118</FirstPage>
    <LastPage>127</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Khorrami Moghaddam</LastName>
        <affiliation locale="en_US">Radiology Department, Allied Faculty, Mazandaran University of Medical Sciences (MazUMS), Sary, Mazandaran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Amir</FirstName>
        <LastName>Hakimi</LastName>
        <affiliation locale="en_US">Health Physics and Dosimetry Research Laboratory, Department of Energy Engineering and Physics, Amirkabir University of&#xD;
Technology, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Mardanshahi</LastName>
        <affiliation locale="en_US">Radiology Department, Allied Faculty, Mazandaran University of Medical Sciences (MazUMS), Sary, Mazandaran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Amir R.</FirstName>
        <LastName>Jalilian</LastName>
        <affiliation locale="en_US">Radiopharmaceutical Research and Development Lab (RRDL), Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Amirfakhrian</LastName>
        <affiliation locale="en_US">Radiology Department, Allied Faculty, Mazandaran University of Medical Sciences (MazUMS), Sary, Mazandaran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Mousavi Anijdan</LastName>
        <affiliation locale="en_US">Radiology Department, Allied Faculty, Babol University of Medical Sciences (BUMS), Babol, Mazandaran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>12</Month>
        <Day>09</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2015</Year>
        <Month>12</Month>
        <Day>09</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Purpose- The main aim of this study was to develop the pharmacokinetic model&#xA0;for the colorectal cancer&#x2019;s complex 166Ho-DOTA-Bevacizumab in normal and&#xA0;tumoral rats to analyze of behavior as a new composition for diagnosing and&#xA0;treatment. The use of compartmental analysis allows a mathematical separation&#xA0;of tissues and organs to determine the concentration of activity in each fraction of&#xA0;interest. Biodistribution studies are expensive and difficult to carry out in humans,&#xA0;but such data can be obtained easily in rodents and rat.
&#xD;


Methods- We have developed a physiologically based pharmacokinetic model for scaling up activity concentration in each organ versus time. The mathematical&#xA0;model uses physiological parameters including organ volumes, blood flow rates,&#xA0;and vascular permeability. The compartments (organs) are connected anatomically.&#xA0;This allows the use of scale-up techniques to predict the new complex distribution&#xA0;in humans in each organ.
&#xD;


Results- The concentration of the new complex was measured in various organs at the different times. The behavior of the complex (166Ho-DOTA-Bevacizumab)&#xA0;was modeled as a function of time in various organs. These data was diagrammed&#xA0;as a time function in the separated graph for each organ between 2-96 hours after&#xA0;injection.
&#xD;


Conclusion- The variation of integrated uptake in organs is described with summationof 6-9 exponential terms and it approximated experimental data with 1-2 %precision. As shown in the diagram the mathematical model and biodistribution data&#xA0;in an experiment has a good joint and coincidence and it is a good sign to save time&#xA0;and cost in the next other researches.</abstract>
    <web_url>https://fbt.tums.ac.ir/index.php/fbt/article/view/55</web_url>
    <pdf_url>https://fbt.tums.ac.ir/index.php/fbt/article/download/55/50</pdf_url>
  </Article>
</Articles>
